(Q34994653)

5 August 2017

1 reference

title

Autism: an emerging 'neuroimmune disorder' in search of therapy (English)

1 reference

5 August 2017

0 references

Theoharis C Theoharides

series ordinal

1

object named as

Theoharis C Theoharides

1 reference

5 August 2017

Duraisamy Kempuraj

2

1 reference

PubMed ID

19640207

5 August 2017

Lyn Redwood

series ordinal

3

1 reference

PubMed ID

19640207

5 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Pharmacotherapy

5 August 2017

1 reference

5 August 2017

10

1 reference

5 August 2017

13

1 reference

5 August 2017

2127-2143

1 reference

Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations

5 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The Epidemiology of Autism Spectrum Disorders *

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Prevalence of autism in a US metropolitan area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Identification and Evaluation of Children With Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

CDC: autism spectrum disorders common.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Epidemiology of Pervasive Developmental Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The rise in autism and the role of age at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Autism and thimerosal-containing vaccines: lack of consistent evidence for an association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Vaccines and autism: evidence does not support a causal association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mercury, vaccines, and autism: one controversy, three histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Thimerosal disappears but autism remains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Developmental regression and autism reported to the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

21 January 2018

What is new in autism?

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Autism spectrum disorders: clinical and research frontiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Immune transcriptome alterations in the temporal cortex of subjects with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Searching for ways out of the autism maze: genetic, epigenetic and environmental clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Common genetic variants on 5p14.1 associate with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

A prospective study of transsulfuration biomarkers in autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Biomarkers of environmental toxicity and susceptibility in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Investigation of antioxidant enzymes in children with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Altered vascular phenotype in autism: correlation with oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Immunity, neuroglia and neuroinflammation in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Is autism an autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The immune response in autism: a new frontier for autism research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Immunological findings in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Gene expression changes in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Altered gene expression and function of peripheral blood natural killer cells in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Cerebrospinal fluid and serum markers of inflammation in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Elevated immune response in the brain of autistic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Abnormal immune response to brain tissue antigen in the syndrome of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Macrophage migration inhibitory factor and autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

TGF-beta 1 inhibits mast cell Fc epsilon RI expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Maternal immune activation alters fetal brain development through interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Inflammatory mediators and modulation of blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Antibrain antibodies in children with autism and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Antibodies against fetal brain in sera of mothers with autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Maternal antibrain antibodies in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Psychological burden of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Clinical practice. Food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Food allergies and food intolerances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Gastrointestinal symptoms in children with an autism spectrum disorder and language regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Tight junctions, leaky intestines, and pediatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Patching a leaky intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Sulphation deficit in "low-functioning" autistic children: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

An IgE mechanism in autistic hypersensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Atopic features in early childhood autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mastocytosis: mediator-related signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mastocytosis: molecular mechanisms and clinical disease heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Diagnostic criteria and classification of mastocytosis: a consensus proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Novel therapeutic targets for autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The critical role of mast cells in allergy and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cells as effector cells: a co-stimulating question

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Critical role of mast cells in inflammatory diseases and the effect of acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The ins and outs of IgE-dependent mast-cell exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Neuropeptides activate human mast cell degranulation and chemokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Oxidative stress stimulates IL-4 and IL-6 production in mast cells by an APE/Ref-1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function-modulating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Human mast cells release Interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Accumulation of Peribronchial Mast Cells in a Mouse Model of Ovalbumin Allergen Induced Chronic Airway Inflammation: Modulation by Immunostimulatory DNA Sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Rectal bleeding in infancy: clinical, allergological, and microbiological examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Rotavirus-induced seizures in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Brain cytokines and neuropsychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Corticotropin-releasing hormone and the blood-brain-barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Anxiety in children and adolescents with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Levels of anxiety and sources of stress in adults with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Differentiation between autism and multiple complex developmental disorder in response to psychosocial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Higher plasma ACTH levels in adults with Asperger syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cells: the immune gate to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mast cells in the brain: evidence and functional significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Leuprolide--a GnRH agonist--prevents restraint stress-induced immunosuppression via sex steroid-independent peripheral mechanism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Chronic caregiver stress and IgE expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Autism, gut-blood-brain barrier, and mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The status of pharmacotherapy for autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Systematic review of the effectiveness of pharmacological treatments for adolescents and adults with autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Evidence-based comprehensive treatments for early autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Pharmacologic treatment for the core deficits and associated symptoms of autism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Health care utilization and expenditures for children with autism: data from U.S. national samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Medication Use Among Children with Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Antipsychotics in the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Antipsychotic drugs in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Atypical Antipsychotics in Children with Pervasive Developmental Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Risperidone in children with autism and serious behavioral problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Hyperserotonemia in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Novel therapeutic targets for enteric nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Quercetin protects against acute immobilization stress-induced behaviors and biochemical alterations in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Pharmacokinetics and metabolism of dietary flavonoids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Chondroitin sulphate inhibits connective tissue mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Opiates, mast cells and histamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

New Developments in Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Mitochondrial disease in autism spectrum disorder patients: a cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

Citalopram treatment in children with autism spectrum disorders and high levels of repetitive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

The Role of Psychosocial Interventions in Bipolar II Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903107789

10.1517/14656560903107789

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

19640207